Clinical Trials Directory

Trials / Completed

CompletedNCT06001840

Promotion and Mitigation Factors Leading to Illegal Tobacco Purchases

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Virginia Polytechnic Institute and State University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the effects of promotion factors and mitigation strategies on legal and illegal tobacco purchases for different tobacco-user types.

Detailed description

In the present study, we propose to examine some promotion factors and mitigation strategies and how they impact tobacco product legal and illegal purchases. Specifically, we have developed an Illegal Experimental Tobacco Marketplace (iETM). The iETM permits us to identify the number, type, and characteristics of tobacco users who would seek illegal tobacco products and the conditions that would induce them to seek that option. The critical questions we seek to answer are whether changes in product standards and availability will engender illegal tobacco purchasing as a function of tobacco user type (e.g., exclusive combustible product users, and dual cigarette/NVP users). Understanding the user types and the relevant conditions will inform greater tailoring of policy to diminish consumer interest in an illegal market.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPromotion factorsIn the full nicotine conditions, participants' preferred cigarettes and NVP products will be available in the LETM and preferred cigarettes will be available in the iETM. In the low nicotine conditions, a ban will permit only VLNCs in the LETM and preferred cigarettes will be available in the iETM.
BEHAVIORALMitigation strategiesPenalties: Penalties will be presented as a 60% chance of getting caught making illegal purchases. The consequences of illegal purchases include not receiving any study products from the ETM if they were caught and randomly drew that trial.

Timeline

Start date
2024-01-04
Primary completion
2025-02-28
Completion
2025-03-31
First posted
2023-08-21
Last updated
2026-02-10
Results posted
2026-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06001840. Inclusion in this directory is not an endorsement.